Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: Innovative radiation oncology Together-Precise, Personalized, Human.
Krug D, Hecht M, Ebert N, Mäurer M, Fleischmann DF, Fokas E, Straube C, Nicolay NH, Hörner-Rieber J, Schmitt D, von Neubeck C, Zamboglou C, Sperk E, Kaul D, Hess J, Corradini S, Seidel C, Gani C, Baues C, Frey B, Blanck O, Gauer T, Niyazi M. Krug D, et al. Among authors: hess j. Strahlenther Onkol. 2021 Dec;197(12):1049-1050. doi: 10.1007/s00066-021-01869-z. Strahlenther Onkol. 2021. PMID: 34731288 Free PMC article. No abstract available.
Improved risk stratification in younger IDH wild-type glioblastoma patients by combining a 4-miRNA signature with MGMT promoter methylation status.
Unger K, Fleischmann DF, Ruf V, Felsberg J, Piehlmaier D, Samaga D, Hess J, Suresh MP, Mittelbronn M, Lauber K, Budach W, Sabel M, Rödel C, Reifenberger G, Herms J, Tonn JC, Zitzelsberger H, Belka C, Niyazi M. Unger K, et al. Among authors: hess j. Neurooncol Adv. 2020 Oct 15;2(1):vdaa137. doi: 10.1093/noajnl/vdaa137. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 33305269 Free PMC article.
Innovative radiation oncology Together - Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in Germany.
Krug D, Hecht M, Ebert N, Mäurer M, Fleischmann DF, Fokas E, Straube C, Nicolay NH, Hörner-Rieber J, Schmitt D, von Neubeck C, Zamboglou C, Sperk E, Kaul D, Hess J, Corradini S, Seidel C, Gani C, Baues C, Frey B, Blanck O, Gauer T, Niyazi M. Krug D, et al. Among authors: hess j. Strahlenther Onkol. 2021 Dec;197(12):1043-1048. doi: 10.1007/s00066-021-01843-9. Epub 2021 Sep 13. Strahlenther Onkol. 2021. PMID: 34515820 Free PMC article.
Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy.
Schnöller LE, Albrecht V, Brix N, Nieto AE, Fleischmann DF, Niyazi M, Hess J, Belka C, Unger K, Lauber K, Orth M. Schnöller LE, et al. Among authors: hess j. Radiat Oncol. 2022 Apr 19;17(1):79. doi: 10.1186/s13014-022-02052-z. Radiat Oncol. 2022. PMID: 35440003 Free PMC article.
Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data.
Schnöller LE, Piehlmaier D, Weber P, Brix N, Fleischmann DF, Nieto AE, Selmansberger M, Heider T, Hess J, Niyazi M, Belka C, Lauber K, Unger K, Orth M. Schnöller LE, et al. Among authors: hess j. Radiat Oncol. 2023 Mar 11;18(1):51. doi: 10.1186/s13014-023-02241-4. Radiat Oncol. 2023. PMID: 36906590 Free PMC article.
DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score.
Unger K, Hess J, Link V, Buchner A, Eze C, Li M, Stief C, Kirchner T, Klauschen F, Zitzelsberger H, Niyazi M, Ganswindt U, Schmidt-Hegemann NS, Belka C. Unger K, et al. Among authors: hess j. Clin Transl Radiat Oncol. 2023 Jan 21;39:100586. doi: 10.1016/j.ctro.2023.100586. eCollection 2023 Mar. Clin Transl Radiat Oncol. 2023. PMID: 36935856 Free PMC article.
Interconnection between DNA damage, senescence, inflammation, and cancer.
Wunderlich R, Ruehle PF, Deloch L, Unger K, Hess J, Zitzelsberger H, Lauber K, Frey B, Gaipl US. Wunderlich R, et al. Among authors: hess j. Front Biosci (Landmark Ed). 2017 Jan 1;22(2):348-369. doi: 10.2741/4488. Front Biosci (Landmark Ed). 2017. PMID: 27814618 Free article. Review.
Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond.
Orth M, Albrecht V, Seidl K, Kinzel L, Unger K, Hess J, Kreutzer L, Sun N, Stegen B, Nieto A, Maas J, Winssinger N, Friedl AA, Walch AK, Belka C, Zitzelsberger H, Niyazi M, Lauber K. Orth M, et al. Among authors: hess j. Front Oncol. 2021 Mar 17;11:612354. doi: 10.3389/fonc.2021.612354. eCollection 2021. Front Oncol. 2021. PMID: 33816244 Free PMC article.
2,170 results